MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J.
Right arrow Articles by Rustum, Y. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J.
Right arrow Articles by Rustum, Y. M.

Vol. 61, Issue 4, 742-748, April 2002

Induction of Biphasic DNA Double Strand Breaks and Activation of Multiple Repair Protein Complexes by DNA Topoisomerase I Drug 7-Ethyl-10-hydroxy-camptothecin

Jiaxi Wu, Ming-biao Yin, Gunnar Hapke, Károly Tóth, and Youcef M. Rustum

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York

Camptothecins demonstrate a broad spectrum of antitumor activity. Although they are known to trap DNA topoisomerase I on DNA, form cleavable complexes, and generate DNA breaks upon collision with DNA or RNA polymerases, the precise mechanisms predictive for antitumor activity remain to be identified. Recent studies using panels of colorectal and breast cancer cell lines indicate that events downstream of cleavable complexes are more relevant. In this study, we chose SN-38, an active metabolite of irinotecan, to characterize DNA double strand breaks and repair mechanisms induced by this type of drugs using a human head and neck squamous cell carcinoma cell line A253. The results showed that 2-h exposure of cells to an IC50 concentration of SN-38 induces biphasic DNA double-strand break (DSBs): an immediate phase, which was greatly reduced within 8 h, and a lagging phase, culminating 24 h after drug removal. Three DNA double-strand break repair protein complexes were activated: DNA-dependent protein kinase (DNA-PK), NBS1-MRE11-RAD50, and BRCA1. Aphidicolin, a DNA polymerase inhibitor, abolished both phase I DSBs and the activation of repair protein complexes, suggesting that they resulted from the collision between the cleavable complex and DNA polymerase of S-phase cells. This is in contrast to ionizing radiation-induced activation of DNA-PK and NBS1-MRE11-RAD50 complexes that occur predominantly among non-S-phase cells. The trigger for phase II DSBs cannot be abolished by aphidicolin. The data also indicate that DNA fragments in the size of 50 to 200 kilobases were detected in the lagging phase. This suggests that the late DNA DSBs were associated with apoptotic cell death.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Ann OncolHome page
B. Burtness, M. Gibson, B. Egleston, R. Mehra, L. Thomas, R. Sipples, M. Quintanilla, J. Lacy, S. Watkins, J. R. Murren, et al.
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer
Ann. Onc., July 1, 2009; 20(7): 1242 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
S. F. El-Khamisy and K. W. Caldecott
TDP1-dependent DNA single-strand break repair and neurodegeneration
Mutagenesis, July 1, 2006; 21(4): 219 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H.-R. Lu, H. Zhu, M. Huang, Y. Chen, Y.-J. Cai, Z.-H. Miao, J.-S. Zhang, and J. Ding
Reactive Oxygen Species Elicit Apoptosis by Concurrently Disrupting Topoisomerase II and DNA-Dependent Protein Kinase
Mol. Pharmacol., October 1, 2005; 68(4): 983 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. Saleh-Gohari, H. E. Bryant, N. Schultz, K. M. Parker, T. N. Cassel, and T. Helleday
Spontaneous Homologous Recombination Is Induced by Collapsed Replication Forks That Are Caused by Endogenous DNA Single-Strand Breaks
Mol. Cell. Biol., August 15, 2005; 25(16): 7158 - 7169.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Jacob, C. Miquel, A. Sarasin, and F.ço. Praz
Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines
Nucleic Acids Res., January 7, 2005; 33(1): 106 - 113.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. E. Kim, S.-Y. Park, C.-H. Hsu, G. E. Dutschman, and Y.-C. Cheng
Synergistic Antitumor Activity of Troxacitabine and Camptothecin in Selected Human Cancer Cell Lines
Mol. Pharmacol., August 1, 2004; 66(2): 285 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
T. Sandal, L. Aumo, L. Hedin, B. T. Gjertsen, and S. O. Doskeland
Irod/Ian5: An Inhibitor of {gamma}-Radiation- and Okadaic Acid-induced Apoptosis
Mol. Biol. Cell, August 1, 2003; 14(8): 3292 - 3304.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics